Maximum Acceptable Passive Blood Pressure in Acute Ischemic Stroke
In patients with acute ischemic stroke who are NOT receiving reperfusion therapy, blood pressure should be left untreated unless it exceeds 220 mm Hg systolic or 120 mm Hg diastolic 1, 2.
Blood Pressure Thresholds Based on Treatment Status
For Patients NOT Receiving Reperfusion Therapy (Permissive Hypertension)
The standard approach is permissive hypertension, allowing elevated blood pressure to persist naturally:
- Systolic BP threshold: 220 mm Hg
- Diastolic BP threshold: 120 mm Hg
Only treat if BP exceeds these levels 1, 2, 3. This recommendation is based on the upper limit of cerebral autoregulation, above which cerebral blood flow becomes directly dependent on blood pressure 4. The rationale is that lowering BP can compromise collateral perfusion to the ischemic penumbra and worsen outcomes 2, 5.
For Patients Receiving IV Thrombolysis (Alteplase)
Before administering alteplase:
- BP must be reduced to ≤185/110 mm Hg 1
- If BP cannot be maintained at or below this level, do NOT give alteplase 1
During and after alteplase (first 24 hours):
- Maintain BP ≤180/105 mm Hg 1
- Monitor BP every 15 minutes for 2 hours, then every 30 minutes for 6 hours, then hourly for 16 hours 1
For Patients Receiving Endovascular Thrombectomy
The optimal BP targets remain less clearly defined 4. Expert consensus suggests:
- Avoid aggressive intraprocedural BP reduction (associated with poor outcomes) 4
- After successful reperfusion, consider reducing systolic BP to 120-140 mm Hg 4
Critical Caveats and Recent Evidence
Important warning from 2026 evidence: Recent major trials (INTERACT4, MR-ASAP, RIGHT-2) and observational data demonstrate that intensive BP lowering before reperfusion therapy is associated with increased risk of death and disability 6. This challenges older recommendations and reinforces the permissive hypertension approach.
Additionally, intensive BP management (targeting <140 mm Hg) after reperfusion therapy probably increases all-cause mortality (RR 1.19) without improving functional outcomes 7.
Exceptions Requiring Lower BP Targets
Override permissive hypertension guidelines in these comorbid conditions 1, 3:
- Acute coronary syndrome/myocardial infarction
- Acute heart failure
- Aortic dissection
- Preeclampsia/eclampsia
- Hypertensive encephalopathy
In these situations, treat BP more aggressively according to the specific condition's requirements.
Preferred Antihypertensive Agents (When Treatment is Needed)
First-line medications 1:
- Labetalol: 10-20 mg IV over 1-2 minutes, may repeat once
- Nicardipine: 5 mg/h IV, titrate up by 2.5 mg/h every 5-15 minutes (maximum 15 mg/h)
- Clevidipine: 1-2 mg/h IV, double dose every 2-5 minutes until desired BP reached (maximum 21 mg/h)
Avoid sodium nitroprusside except for extreme hypertension (diastolic >140 mm Hg), as it adversely affects cerebral autoregulation and intracranial pressure 1, 2.
Common Pitfalls to Avoid
Do not treat BP aggressively in non-thrombolysis candidates - This can extend infarct size by reducing penumbral perfusion 2, 5
Do not use the 220/120 threshold for thrombolysis candidates - They require the stricter 185/110 threshold before treatment 1
Recognize spontaneous BP decline - Most patients experience natural BP reduction within hours; premature treatment may cause excessive hypotension 4, 5
Monitor for BP variability - Greater BP fluctuation after thrombolysis increases hemorrhage risk 1